#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Non-small cell lung cancer metastatic Asthma Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Acute lymphocytic leukaemia recurrent Central nervous system lymphoma Multifocal motor neuropathy Nephrotic syndrome Marginal zone lymphoma Systemic candida Idiopathic pulmonary fibrosis Mitochondrial myopathy Postprandial hypoglycaemia Neuropathy peripheral Eosinophilic granulomatosis with polyangiitis Von Hippel-Lindau disease Duchenne muscular dystrophy gene carrier Congenital aplastic anaemia Glomerulonephritis chronic More trials…

    Learn about Rare Diseases

    Chondrosarcoma – Trials in Disease Idiopathic pulmonary fibrosis – Trials in Disease Extranodal marginal zone B-cell lymphoma (MALT type) – Treatment Epidermolysis bullosa – Life with Disease Alexander disease – Treatment Loeys-Dietz syndrome – Treatment Hereditary neuropathic amyloidosis – Life with Disease Biotinidase deficiency – Treatment Primary biliary cholangitis – Treatment Systemic sclerosis pulmonary – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Diltiazem Bi-1808 Interleukin-1 DAPIGLUTIDE Azithromycin Dihydrate Water For Injection Izaflortaucipir (18F) Iron Sucrose Hyoscine Ephedrine Hydrochloride Clemastine Fumarate Digitoxin Lapatinib Niraparib Mycophenolic Acid Indacaterol Acetate Sorafenib Pseudoephedrine Hydrochloride Kan-101 Mps-216 More therapies…

    Learn about Your Condition

    Prostate cancer Hypocalcaemia Fibrosarcoma Gouty arthritis Alveolar proteinosis Leukocyte adhesion deficiency Kaposi's sarcoma Craniotomy Dyspnoea Abdominal pain Mite allergy Bacterial prostatitis Penile cancer Relapsing multiple sclerosis Actinic keratosis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Nervous System Diseases

  • Study of tasimelteon compared to placebo for treating insomnia in children

    Recruiting

    3 1 1
    Investigated Drugs:
    • Tasimelteon
    Germany Poland

  • Safety and Feasibility of Home Use On-Body Injection System for Subcutaneous Ocrelizumab in Adults with Multiple Sclerosis

    Recruiting

    3 1 1
    Investigated Diseases:
    • Multiple sclerosis
    Investigated Drugs:
    • Ocrelizumab
    France Italy Poland Spain

  • A Phase 3 Study of Orelabrutinib to Delay Disability Progression in Patients with Non‑Active Secondary Progressive Multiple Sclerosis

    Recruiting

    3 1
    Austria Belgium Bulgaria Croatia Czechia Denmark +15

  • Safety Study of NB-4746 with Riluzole and Placebo in Adults with Amyotrophic Lateral Sclerosis (ALS)

    Recruiting

    1 1 1
    Investigated Diseases:
    • Amyotrophic lateral sclerosis
    Investigated Drugs:
    • Riluzole
    Italy The Netherlands Poland Spain

  • Phase 3 Randomized Study of ALKS 2680 for Excessive Daytime Sleepiness in Adults with Narcolepsy Type 1

    Recruiting

    3 1
    Investigated Diseases:
    • Narcolepsy
    Investigated Drugs:
    • Alks 2680
    Belgium France Italy The Netherlands Spain

  • Phase 2 Randomized Study of Povetacicept to Assess Safety and Effectiveness in Adults with Generalized Myasthenia Gravis

    Recruiting

    2 1
    Investigated Diseases:
    • Myasthenia gravis
    Investigated Drugs:
    • Povetacicept
    Poland
1 2 3 … 141
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!